PPT-Scotland’s End-of-Life, Orphan, and Ultra-orphan criteria: impact on patient access

Background Drugs to treat rare conditions orphan and ultraorphan drugs and drugs used to treat patients in their last months of life are contentious in funding

cancer drugs nice access drugs cancer access nice reforms smc criteria life decisions decision submissions orphan eol process rejected

Presentation Embed Code

<iframe width="560" height="315" src="https://www.docslides.com/embed/634521" frameborder="0" allowfullscreen></iframe>

Download Presentation

Download Presentation The PPT/PDF document "Scotland’s End-of-Life, Orphan, and Ul..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.